Clinical Trial Update: Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results evaluate the efficacy and safety of rimonabant as an aid to maintaining smoking cessation. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Maintenance of Smoking Cessation | Phase 3 | Status: COMPLETED